In Vivo CAR T: A New Route to Treating Autoimmune Disease - Top-Institutions - MDSpire

In Vivo CAR T: A New Route to Treating Autoimmune Disease

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

  • By

  • Ying K. Tam

  • Sean Semple

  • July 13, 2026

  • 7 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    University of Sydney
    University of Sydney

    Sydney, NSW

    Key Differentiators

    • Immunology

  • #2

    Royal Prince Alfred Hospital
    Royal Prince Alfred Hospital

    Sydney, NSW

    Key Differentiators

    • Immunology

  • #3

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Immunology

Original Source(s)

In Vivo CAR T: A New Route to Treating Autoimmune Disease

  • by Ying K. Tam, Sean Semple

  • July 13, 2026

Related Content

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

The risk association between systemic lupus erythematosus and glaucoma: a systematic review and meta-analysis

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding